CANTON, Mass. and LAS VEGAS, Oct. 6, 2016 /PRNewswire/ -- This week, new data and information featuring Organogenesis' FDA-approved bioengineered cell-based products Apligraf® and Dermagraft®, and wound management products PuraPly™ and PuraPly Antimicrobial (AM)™...